HSHHSH Health Technology Supplier Hub
Home › Suppliers › Agfa HealthCare › Risk

Agfa HealthCare: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

Part of Agfa-Gevaert (AGFB.BR).

Latest full-year results not yet captured by HSH.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

No adverse media involving Agfa HealthCare found in HSH's search of the last 24 months.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

No data breaches, cyber incidents or regulator action involving Agfa HealthCare found in HSH's search of the last 24 months. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

Nov 2025: AGFA Healthcare Corp began an FDA Class 2 recall of 35 US DR 800 X-ray systems, which could exceed the maximum allowed air kerma rate during pulsed fluoroscopy in certain settings; a generator software update was to be installed.

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

May 2026: Agfa HealthCare reported multiple Enterprise Imaging go-lives in North America in Q1 2026, without naming customers. May 2025: Queen Elizabeth Hospital King's Lynn NHS FT renewed Agfa Enterprise Imaging maintenance for a year.

Researched 10 Nov 2026